TFF Pharmaceuticals Inc (TFFP)
2.20
+0.04
(+1.85%)
USD |
NASDAQ |
May 17, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
TFF Pharmaceuticals Enterprise Value: -0.0366M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -0.0366M |
| May 16, 2024 | -0.0366M |
| May 15, 2024 | -0.4145M |
| May 14, 2024 | -0.7924M |
| May 13, 2024 | -0.9184M |
| May 10, 2024 | -0.5657M |
| May 09, 2024 | 0.0137M |
| May 08, 2024 | -0.213M |
| May 07, 2024 | 0.0641M |
| May 06, 2024 | -0.0366M |
| May 03, 2024 | -0.3641M |
| May 02, 2024 | 0.7443M |
| May 01, 2024 | 1.248M |
| April 30, 2024 | 1.399M |
| April 29, 2024 | 1.349M |
| April 26, 2024 | 1.882M |
| April 25, 2024 | 2.205M |
| April 24, 2024 | 2.105M |
| April 23, 2024 | 2.004M |
| April 22, 2024 | 1.021M |
| April 19, 2024 | 2.357M |
| April 18, 2024 | 2.420M |
| April 17, 2024 | 2.685M |
| April 16, 2024 | 2.860M |
| April 15, 2024 | 3.390M |
| Date | Value |
|---|---|
| April 12, 2024 | 4.221M |
| April 11, 2024 | 4.498M |
| April 10, 2024 | 4.775M |
| April 09, 2024 | 5.657M |
| April 08, 2024 | 5.254M |
| April 05, 2024 | 5.833M |
| April 04, 2024 | 6.690M |
| April 03, 2024 | 7.118M |
| April 02, 2024 | 6.942M |
| April 01, 2024 | 10.67M |
| March 28, 2024 | 9.738M |
| March 27, 2024 | 11.12M |
| March 26, 2024 | 10.87M |
| March 25, 2024 | 13.16M |
| March 22, 2024 | 13.89M |
| March 21, 2024 | 13.99M |
| March 20, 2024 | 13.38M |
| March 19, 2024 | 15.54M |
| March 18, 2024 | 12.53M |
| March 15, 2024 | 11.99M |
| March 14, 2024 | 12.58M |
| March 13, 2024 | 13.03M |
| March 12, 2024 | 13.03M |
| March 11, 2024 | 14.67M |
| March 08, 2024 | 13.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9184M
Minimum
May 13 2024
409.77M
Maximum
Jan 20 2021
112.02M
Average
100.04M
Median
Nov 11 2019
Enterprise Value Benchmarks
| Lifecore Biomedical Inc | -- |
| Jaguar Health Inc | 96.09M |
| Genprex Inc | -1.866M |
| Aquestive Therapeutics Inc | 216.71M |
| NovaBay Pharmaceuticals Inc | 5.156M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.762M |
| Total Expenses (Quarterly) | 5.369M |
| EPS Diluted (Quarterly) | -1.60 |
| Earnings Yield | -560.2% |